Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 9:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 1,748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Premature Endothelial Dysfunction, Rheumatoid Arthritis, Healthy
Interventions: Not listed
Lead sponsor: Orrin M Troum, M.D. and Medical Associates; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Obesity
Interventions: AMRA(r) Researcher Image reconstruction software, MRI: radiofrequency coils (Device Manufacturer: Siemens Medical Solutions USA, Inc.), MRI: Research pulse sequences (Device Manufacturer: NIH), MRI: Image Reconstruction and Analysis Software (Device Manufacturer: NIH), Bluetooth-enabled glucometer, Remote tailored-to-place coaching (TPC), Standard remote coaching (SRC), Run-in physical-activity monitoring, Ambulatory blood-pressure monitor, Polysomnography equipment; Device · Other
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years to 75 Years · Female only
Enrollment: 325 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Diseases
Interventions: Heart Matters; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Rocky Mount, North Carolina

Conditions: Prostatectomy
Interventions: Exercise; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Weight Loss, Men, Lifestyle Risk Reduction, Cardiovascular Diseases, Obesity
Interventions: Self-guided lifestyle intervention; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Atrial Fibrillation
Interventions: Flecainide, Sotalol; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 100 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 4
States / cities: Chicago, Illinois • Oak Lawn, Illinois

Conditions: Impact of Singing, Cardiovascular Health, Cardiovascular Risk Factors, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Breast Cancer
Interventions: RealRisks Decision Aid; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 40 Years to 79 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: high caloric expenditure exercise, low caloric expenditure exercise plus dietary counseling; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 21 Years to 90 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Diabetic Retinopathy
Interventions: Octreotide Acetate in Microspheres, Placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Sudden Cardiac Death
Interventions: Not listed
Lead sponsor: Harbinger Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 4
States / cities: Phoenix, Arizona • Wichita, Kansas • Boston, Massachusetts + 1 more

Conditions: Peripheral Arterial Disease
Interventions: Therapeutic Device; Device
Lead sponsor: Vibrato Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Orange, California

Conditions: Diabetes Mellitus
Interventions: Raisins, Snacks; Other
Lead sponsor: Louisville Metabolic and Atherosclerosis Research Center; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Vascular Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension in Pregnancy, Gestational Diabetes, Cervical Dysplasia
Interventions: Postpartum follow up card, Control; Behavioral · Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 157 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Cardiovascular (CV) Risk
Interventions: Air filtration systems without filters (sham); Device
Lead sponsor: Michigan State University; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Coronary Heart Disease, Stroke, Hyperlipidemia, Hypertension
Interventions: Enhance health lifestyle changes and medication compliance; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 35 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Stanford, California

Conditions: Stress, Blood Pressure, Cardiovascular Diseases (CVD)
Interventions: Stress Management and Resiliency Training Program, Usual Care; Behavioral · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hypertension, Hyperlipidemias
Interventions: Atorvastatin, placebo; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 35 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Multiple Myeloma
Interventions: Carfilzomib, Revlimid, Dexamethasone; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: PTSD
Interventions: Cognitive Processing Therapy - Cognitive; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Diseases, Coronary Disease
Interventions: Exercise; Behavioral
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 50 Years to 65 Years · Female only
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: HIV, Cardiovascular Disease
Interventions: Canakinumab, Placebo; Drug
Lead sponsor: Priscilla Hsue, MD; Other
Eligibility: 40 Years to 59 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Prevention of Stroke or Systemic Embolism, Atrial Fibrillation
Interventions: Asundexian (BAY2433334), Apixaban, Asundexian matching placebo, Apixaban matching placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 14,830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 163
States / cities: Dothan, Alabama • Fairhope, Alabama • Mobile, Alabama + 144 more

Search by objective public record fields.

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina

Exercise Training Among Men With Prostate Cancer

A Novel Approach to Reducing Adiposity Among Young Men

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

The Singing Heart Study

Decision Support for Chemoprevention

Methods of Weight Loss in Overweight Coronary Patients

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias

A Non-significant Risk Clinical Study to Assess Perfusion Changes With Application of a TUS for Patients With PAD

Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes Mellitus

The Framingham Study: Examining DNA Markers and Links to Diseases

Reshaping Postpartum Follow-up

PM2.5 Exposure, Obesity, and Cardiovascular Health

Heart Disease on the Mend

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk

Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women

Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke